ArticleMolecular oncology2015

Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control.

Carin K Ingemarsdotter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.